Source:http://linkedlifedata.com/resource/pubmed/id/20926011
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-10-7
|
pubmed:abstractText |
Protease-activated receptor-2 (PAR-2) is essential for the initiation and development of tumours, suggesting that the detection of PAR-2 expression might serve as a clinical marker in the prediction or diagnosis of clinical outcomes of malignant neoplasia. Using immunohisto chemical methods, this study investigated whether the detection of PAR-2 protein had clinical implications for patients with oesophageal squamous cell carcinoma (OSCC). PAR-2 protein was present at a high level in primary OSCC sites but at a low level in normal oesophageal tissue. The level of PAR-2 protein in tumours was significantly correlated with the clinical stage and histological grade of disease. Patients with tumours highly positive for PAR-2 protein had a significantly worse prognosis than those with lower PAR-2 levels. Thus, the over-expression of PAR-2 is a characteristic feature of OSCC and suggests that the immuno histochemical detection of raised levels of PAR-2 may be a potentially useful prognostic indicator.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-0605
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1381-8
|
pubmed:meshHeading |
pubmed-meshheading:20926011-Adult,
pubmed-meshheading:20926011-Aged,
pubmed-meshheading:20926011-Aged, 80 and over,
pubmed-meshheading:20926011-Carcinoma, Squamous Cell,
pubmed-meshheading:20926011-Demography,
pubmed-meshheading:20926011-Esophageal Neoplasms,
pubmed-meshheading:20926011-Female,
pubmed-meshheading:20926011-Humans,
pubmed-meshheading:20926011-Immunohistochemistry,
pubmed-meshheading:20926011-Kaplan-Meier Estimate,
pubmed-meshheading:20926011-Male,
pubmed-meshheading:20926011-Middle Aged,
pubmed-meshheading:20926011-Receptor, PAR-2
|
pubmed:articleTitle |
Prognostic value of protease-activated receptor 2 expression in oesophageal squamous cell carcinoma.
|
pubmed:affiliation |
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|